Effect of early prophylactic low-dose recombinant human erythropoietin on retinopathy of prematurity in very preterm infants

Sun, HQ; Song, J; Kang, WQ; Wang, Y; Sun, XT; Zhou, CC; Xiong, H; Xu, FL; Li, MC; Zhang, XL; Yu, ZY; Peng, XR; Li, BB; Xu, YR; Xing, S; Wang, XY; Zhu, CL

Zhu, CL (corresponding author), Univ Gothenburg, Ctr Brain Repair & Rehabil, Inst Neurosci & Physiol, Gothenburg, Sweden.

JOURNAL OF TRANSLATIONAL MEDICINE, 2020; 18 (1):

Abstract

Background: Very preterm infants are at risk of developing retinopathy of prematurity (ROP). Recombinant human erythropoietin (rhEPO) is routinely use......

Full Text Link